umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Natural product inspired library synthesis – Identification of 2,3-diarylbenzofuran and 2,3-dihydrobenzofuran based inhibitors of Chlamydia trachomatis
Umeå University, Faculty of Science and Technology, Department of Chemistry.ORCID iD: 0000-0003-2721-6074
Umeå University, Faculty of Medicine, Department of Clinical Microbiology, Virology. (Åsa Gylfe)
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Show others and affiliations
2018 (English)In: European Journal of Medicinal Chemistry, ISSN 0223-5234, E-ISSN 1768-3254, Vol. 143, p. 1077-1089Article in journal (Refereed) Published
Abstract [en]

A natural product inspired library was synthesized based on 2,3-diarylbenzofuran and 2,3-diaryl-2,3-dihydrobenzofuran scaffolds. The library of forty-eight compounds was prepared by utilizing Pd-catalyzed one-pot multicomponent reactions and ruthenium-catalyzed intramolecular carbenoid C-H insertions. The compounds were evaluated for antibacterial activity in a panel of test systems including phenotypic, biochemical and image-based screening assays. We identified several potent inhibitors that block intracellular replication of pathogenic Chlamydia trachomatis with IC50 ≤ 3 μM. These new C. trachomatis inhibitors can serve as starting points for the development of specific treatments that reduces the global burden of C. trachomatis infections.

Place, publisher, year, edition, pages
Elsevier, 2018. Vol. 143, p. 1077-1089
Keywords [en]
2, 3-diaryl-2, 3-dihydrobenzofuran, 2, 3-diaryl-benzofuran, Antibacterial, Benzofuran, Chlamydia
National Category
Organic Chemistry Biological Sciences
Identifiers
URN: urn:nbn:se:umu:diva-143062DOI: 10.1016/j.ejmech.2017.11.099ISI: 000428216700089PubMedID: 29232584OAI: oai:DiVA.org:umu-143062DiVA, id: diva2:1167289
Funder
Swedish Foundation for Strategic Research , SB12-0022Swedish Research Council, 621-2014-4670Available from: 2017-12-18 Created: 2017-12-18 Last updated: 2018-08-24Bibliographically approved
In thesis
1. Towards novel antibacterials: Synthesis and identification of natural product inspired inhibitors of Chlamydia trachomatis and development of chemical probes targeting virulence of Pseudomonas aeruginosa
Open this publication in new window or tab >>Towards novel antibacterials: Synthesis and identification of natural product inspired inhibitors of Chlamydia trachomatis and development of chemical probes targeting virulence of Pseudomonas aeruginosa
2018 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Antibiotic resistance has evolved significantly to become one of the serious threats to public health today. Yet, the pipeline of new antibiotics is drying up and is lagging behind the challenging needs. As a contribution to this recurrent need for novel antibacterials, we applied multidisciplinary strategies to identify small-molecule antibacterials against Chlamydia trachomatis and antivirulence agents against Pseudomonas aeruginosa infections. These strategies included:

1. Synthesis of a focused compounds library inspired by natural product scaffolds followed by phenotypic screening against Chlamydia trachomatis. (Paper I)

(-)-Hopeaphenol is a polyphenol natural product that was identified as an antivirulence agent against Y. pseudotuberculosis and P. aeruginosa. Hopeaphenol core scaffold, 2,3-diaryl-2,3-dihydrobenzofuran, is ubiquitous in polyphenolic phytochemicals. In this thesis, a focused library of forty-eight compounds was synthesized based on 2,3-diarylbenzofuran and 2,3-diaryl-2,3- dihydrobenzofuran. The library was then explored for antibacterial properties in a number of screening assays and resulted in five novel antichlamydial compounds with inhibition potency down to sub-micromolar. The identified molecules also inhibited the growth of different clinical presentations of C. trachomatis, one of the most common sexually transmitted disease worldwide.

2. Target-based screening against the P. aeruginosa virulence factor using enzymatic and biophysical assays. (Paper II-IV)

P. aeruginosa is a Gram-negative opportunistic pathogen with remarkable antibiotic resistance that is associated with a wide range of clinical infections. An alternative strategy to develop novel and selective antibacterials is to target the bacterial virulence factors, i.e. the ability of the bacteria to promote disease, thus ‘disarming’ the pathogens instead of killing them. P. aeruginosa employs its virulence factor, the type III secretion system (T3SS), to inject toxins (e.g. ExoS) into the eukaryotic cytosol. In one part of this thesis, we utilized enzymatic assay and identified inhibitors against the P. aeruginosa T3S toxin (ExoS). A follow up structure-activity relationship analysis was established and resulted in five (low micromolar) inhibitors of ExoS ADP-ribosylation enzymatic activity. In another part, we used surface plasmon resonance biophysical assay and identified small molecule binders of T3S translocation protein (PcrV). The primary SAR analysis was established and showed the antivirulence properties of these molecules and the potential to expand them further as novel antibacterials.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2018. p. 95
Keywords
Antibacterials, antibiotics, small molecules, natural products, benzofuran, dihydrobenzofuran, the type III secretion system, Pseudomonas aeruginosa, Chlamydia trachomatis, phenotypic screening, high-throughput screening, surface plasmon resonance, drug discovery, bacterial toxins, enzyme inhibitors
National Category
Natural Sciences Organic Chemistry
Research subject
Organic Chemistry
Identifiers
urn:nbn:se:umu:diva-150970 (URN)978-91-7601-917-7 (ISBN)
Public defence
2018-09-14, KB.E3.03 (Stora hörsalen), KBC-huset, Umeå, 09:00 (English)
Opponent
Supervisors
Funder
Swedish Foundation for Strategic Research , SSF, SB12-0022
Available from: 2018-08-24 Created: 2018-08-21 Last updated: 2018-08-21Bibliographically approved

Open Access in DiVA

fulltext(4558 kB)109 downloads
File information
File name FULLTEXT01.pdfFile size 4558 kBChecksum SHA-512
d234dc64893282ba427b6222ca1e3ed20157ac50f04e6e4b3a5e7f700093ad6160280667ed328aae66b046b9f29250ff5bb739833a1d11b703fe1c97e942d3d7
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Saleeb, MichaelMojica, SergioEriksson, Anna U.Andersson, C. DavidGylfe, ÅsaElofsson, Mikael

Search in DiVA

By author/editor
Saleeb, MichaelMojica, SergioEriksson, Anna U.Andersson, C. DavidGylfe, ÅsaElofsson, Mikael
By organisation
Department of ChemistryVirologyClinical BacteriologyMolecular Infection Medicine Sweden (MIMS)Umeå Centre for Microbial Research (UCMR)
In the same journal
European Journal of Medicinal Chemistry
Organic ChemistryBiological Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 109 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 542 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf